Home › Sudden Cardiac Arrest › NCT05558228
Accuracy of Doppler Ultrasound Versus Manual Palpation of Pulse in Cardiac Arrest
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * 18+ years of age * In cardiac arrest at the North Shore University Hospital emergency department * Arterial line placed during cardiac arrest resuscitation Exclusion Criteria: * Traumatic cardiac arrest * Patients without bilateral lower extremities
About the study
The FloPatch FP120 device is indicated for use for the noninvasive assessment of blood flow in the carotid artery. The FloPatch FP120 device uses ultrasound and the Doppler effect to non-invasively assess the flow of flood. In this study, the FloPatch FP120 will be applied to the neck at the location of the carotid artery on cardiac arrest patients in the emergency department. FloPatch FP120 data will be compared with arterial line blood pressure to assess for accuracy of pulse checks among cardiac arrest patients in the emergency department.
What is being tested
- FloPatch FP120 (device)
Sponsor: Northwell Health · Participants: 35 · Started: Sep 6, 2022
Contact the study team
- Timmy Li, PhD · Phone: 516-240-3933
Official record on ClinicalTrials.gov — NCT05558228
Locations in the U.S.
| New York | North Shore University Hospital, Manhasset |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.